AVITA MEDICAL INC. - Announcements

0.78%

$1.28

Market Cap $93.90M

Healthcare Biotechnology

AVITA Medical, Inc. is a therapeutic acute wound care company. The Company’s technologies... AVITA Medical, Inc. is a therapeutic acute wound care company. The Company’s technologies optimize wound healing, effectively accelerating the time to patient recovery. At the forefront of its platform is the RECELL System for the treatment of thermal burn wounds and full-thickness skin defects. RECELL harnesses the healing properties of a patient’s own skin to create Spray-On Skin Cells, offering a solution for improved clinical outcomes at the point-of-care. In the United States, it also holds the exclusive rights to market, sell, and distribute Cohealyx, an AVITA Medical-branded collagen-based dermal matrix, and PermeaDerm, a biosynthetic wound matrix. Its technologies are designed to optimize skin restoration procedures, effectively accelerating patient healing and recovery. Its solutions improve the healing outcomes for patients with traumatic injuries and surgical repairs, addressing critical healing needs that arise from unpredictable and life-changing events.More

Actinogen Medical (ASX:ACW) reaches 100th participant milestone in Alzheimer’s Disease Trial & confirms interim analysis timeline.

Announcements

Filter Results

All Price Sensitive Only

AVH	708(5) Cleansing Notice and Appendix 3B		17/09/09	57.36KB	Share
AVH	ReCell Presentations at EU Burns Congress		14/09/09	34.01KB	Share
AVH	Cleansing Statement 708A(5)		10/09/09	23.4KB	Share
AVH	Appendix 3B		10/09/09	30.99KB	Share
AVH	Cleansing Statement Section 708A (5)		03/09/09	31.24KB	Share
AVH	Appendix 3B		03/09/09	30.96KB	Share
AVH	Preliminary Final Report	PRICE SENSITIVE	31/08/09	68.4KB	Share
AVH	Review of FY2009 and Highlights		31/08/09	30.96KB	Share
AVH	ReCell Cleared for Sales in China	PRICE SENSITIVE	17/08/09	32.17KB	Share
AVH	USA ReCell AFIRM Clinical Study to Commence	PRICE SENSITIVE	13/08/09	35.97KB	Share
AVH	Appendix 3B		12/08/09	31.2KB	Share
AVH	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/09	39.58KB	Share
AVH	Investor Update		30/07/09	473.89KB	Share
AVH	Terms of Funding Facility		22/07/09	31.26KB	Share
AVH	Secures $5m Funding Facility	PRICE SENSITIVE	20/07/09	32.46KB	Share
AVH	Awarded $2m to accelerate approval in US market	PRICE SENSITIVE	27/05/09	37.9KB	Share
AVH	Quarterly Cash Flow	PRICE SENSITIVE	01/05/09	29.2KB	Share
AVH	Investor Presentation		21/04/09	1.09MB	Share
AVH	Investor Update		16/04/09	234.19KB	Share
AVH	Respiratory Sales up 72%	PRICE SENSITIVE	02/04/09	35.49KB	Share
AVH	Half Yearly Report and Accounts	PRICE SENSITIVE	27/02/09	320.82KB	Share
AVH	Avita Streamlines Operations and Reduces costs	PRICE SENSITIVE	11/02/09	34.74KB	Share
AVH	Quarterly Cash Flow - Cash receipts up over 600%	PRICE SENSITIVE	30/01/09	65.63KB	Share
AVH	Avita Medical Receives ISO Certification	PRICE SENSITIVE	14/01/09	28.78KB	Share
AVH	ReCell Vitiligo publication - British Journal of Dermatology		09/01/09	33.99KB	Share
AVH	French Ministry of Health in 200 Patient ReCell Study	PRICE SENSITIVE	16/12/08	33.66KB	Share
AVH	Appendix 3B		15/12/08	45.79KB	Share
AVH	Change of Director's Interest Notice		11/12/08	14.39KB	Share

AVH708(5) Cleansing Notice and Appendix 3B
17/09/09		57.36KB	Share
AVHReCell Presentations at EU Burns Congress
14/09/09		34.01KB	Share
AVHCleansing Statement 708A(5)
10/09/09		23.4KB	Share
AVHAppendix 3B
10/09/09		30.99KB	Share
AVHCleansing Statement Section 708A (5)
03/09/09		31.24KB	Share
AVHAppendix 3B
03/09/09		30.96KB	Share
AVHPreliminary Final Report
31/08/09	PRICE SENSITIVE	68.4KB	Share
AVHReview of FY2009 and Highlights
31/08/09		30.96KB	Share
AVHReCell Cleared for Sales in China
17/08/09	PRICE SENSITIVE	32.17KB	Share
AVHUSA ReCell AFIRM Clinical Study to Commence
13/08/09	PRICE SENSITIVE	35.97KB	Share
AVHAppendix 3B
12/08/09		31.2KB	Share
AVHAppendix 4C - quarterly
31/07/09	PRICE SENSITIVE	39.58KB	Share
AVHInvestor Update
30/07/09		473.89KB	Share
AVHTerms of Funding Facility
22/07/09		31.26KB	Share
AVHSecures $5m Funding Facility
20/07/09	PRICE SENSITIVE	32.46KB	Share
AVHAwarded $2m to accelerate approval in US market
27/05/09	PRICE SENSITIVE	37.9KB	Share
AVHQuarterly Cash Flow
01/05/09	PRICE SENSITIVE	29.2KB	Share
AVHInvestor Presentation
21/04/09		1.09MB	Share
AVHInvestor Update
16/04/09		234.19KB	Share
AVHRespiratory Sales up 72%
02/04/09	PRICE SENSITIVE	35.49KB	Share
AVHHalf Yearly Report and Accounts
27/02/09	PRICE SENSITIVE	320.82KB	Share
AVHAvita Streamlines Operations and Reduces costs
11/02/09	PRICE SENSITIVE	34.74KB	Share
AVHQuarterly Cash Flow - Cash receipts up over 600%
30/01/09	PRICE SENSITIVE	65.63KB	Share
AVHAvita Medical Receives ISO Certification
14/01/09	PRICE SENSITIVE	28.78KB	Share
AVHReCell Vitiligo publication - British Journal of Dermatology
09/01/09		33.99KB	Share
AVHFrench Ministry of Health in 200 Patient ReCell Study
16/12/08	PRICE SENSITIVE	33.66KB	Share
AVHAppendix 3B
15/12/08		45.79KB	Share
AVHChange of Director's Interest Notice
11/12/08		14.39KB	Share

REFRESH

First 10 11 12 13 14

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.28		Change -0.010(0.78%)		Mkt cap ! $93.90M

Open	High	Low	Value	Volume
$1.29	$1.30	$1.27	$564.2K	439.6K

Buyers (Bids)

No.	Vol.	Price($)
4	23103	$1.28

Sellers (Offers)

Price($)	Vol.	No.
$1.28	518	1

View Market Depth

No.	Vol.	Price($)
4	23103	1.275
3	4776	1.270
2	5371	1.265
7	34631	1.260
4	9604	1.255

Price($)	Vol.	No.
1.280	518	1
1.300	10547	1
1.310	1201	1
1.315	1617	1
1.320	1024	1

Last trade - 16.10pm 11/09/2025 (20 minute delay)


Last $1.28		Change -0.010 ( 0.30 %)
Open	High	Low	Volume
$1.29	$1.30	$1.27	69253
Last updated 15.59pm 11/09/2025 ?

AVH (ASX) Chart

AVITA MEDICAL INC. - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories